| Product Code: ETC12772898 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Non-Small Cell Lung Cancer Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Non-Small Cell Lung Cancer Market - Industry Life Cycle |
3.4 Poland Non-Small Cell Lung Cancer Market - Porter's Five Forces |
3.5 Poland Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Poland Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Poland Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Poland Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Poland Non-Small Cell Lung Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Poland |
4.2.2 Technological advancements in treatment options and diagnostics |
4.2.3 Rising awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High treatment costs and limited reimbursement policies |
4.3.3 Limited access to advanced healthcare facilities in rural areas |
5 Poland Non-Small Cell Lung Cancer Market Trends |
6 Poland Non-Small Cell Lung Cancer Market, By Types |
6.1 Poland Non-Small Cell Lung Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021 - 2031F |
6.1.5 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031F |
6.1.6 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Poland Non-Small Cell Lung Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 Poland Non-Small Cell Lung Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4 Poland Non-Small Cell Lung Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.4.3 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Tumor Management, 2021 - 2031F |
6.4.4 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4.5 Poland Non-Small Cell Lung Cancer Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
7 Poland Non-Small Cell Lung Cancer Market Import-Export Trade Statistics |
7.1 Poland Non-Small Cell Lung Cancer Market Export to Major Countries |
7.2 Poland Non-Small Cell Lung Cancer Market Imports from Major Countries |
8 Poland Non-Small Cell Lung Cancer Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rate of novel therapies in non-small cell lung cancer |
8.3 Percentage of early-stage diagnoses in the population |
8.4 Patient satisfaction with treatment outcomes |
9 Poland Non-Small Cell Lung Cancer Market - Opportunity Assessment |
9.1 Poland Non-Small Cell Lung Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Poland Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Poland Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Poland Non-Small Cell Lung Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Poland Non-Small Cell Lung Cancer Market - Competitive Landscape |
10.1 Poland Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024 |
10.2 Poland Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here